Strides Arcolab acquires Polish unit

Strides Arcolab has completed the acquisition of the former ICN Valeant sterile manufacturing unit in Warsaw, Poland.

Pharmaceutical company Strides Arcolab Ltd said on Thursday that Strides Polska has completed the acquisition of the former ICN Valeant sterile manufacturing unit in Warsaw, Poland.

HT Image

The acquisition would enable Strides Polska to begin expansion of its operations in eastern Europe as part of Strides Global Network, the company informed the stock exchanges.

Strides Polska's facility has added to Strides Arcolab's European operations which started with the acquisition of the Italian pharmaceutical plant, Beltapharm in 2006.

"This addition further strengthens Strides presence in Europe and allows us to focus on developing the Polish operations into a strategic part of our manufacturing network, as well as allowing us to promote our products and services in the 'New Europe'," the company's President Global Manufacturing Paul Moore said.

The Strides Group stated that it intends to install additional and new capacity, in sterile dose form at the plant and the expansion is planned to allow Strides Polska to cater to global as well as European markets.

"The planned expansion will create a state-of-the-art sterile facility which will lead to increased production capabilities for the Strides group. Our planned investments will increase present production capacity as well as introducing new sterile dose forms to the site, " Moore added.